New Drug Channels Institute Study: Biosimilars Are Delivering Higher Profits for Drug Distributors

The adoption of administered biosimilars has accelerated significantly over the past year, as prices drop and plans relax medical benefit formularies. PHILADELPHIA (PRWEB) October 05, 2021 Today Drug Channels Institute (DCI) released its exclusive analysis of U.S. prescription drug distribution channels.

Read the source article at PRWeb
2021-10-05 01:00:00